Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities (ClinicalTrials.gov Identifier: NCT05051579)
Water counts
One of the most important outcomes is reduced risk of major cardiovascular events
Central appetite regulation : GLP-1 receptors in the hypothalamus and other brain regions involved in appetite control are activated, leading to reduced hunger and food intake
Market Regional Analysis: North America, Europe, Asia-Pacific Which Factors Drive the GLP-1 Market in North America
US$ 22.68
US$ 22.37
US$ 22.97
US$ 24.21
